South Korea · Delayed Price · Currency is KRW DongKook Pharmaceutical Company Description
DongKook Pharmaceutical Co., Ltd. provides pharmaceutical products in South Korea and internationally.
It produces active pharmaceutical ingredients, including propofol, streptokinase, and teicoplanin; disposable syringes; and pills, capsules, and ointments, as well as small volume parentral, large volume parentral, and lyophilized injectable drug injections.
The company also offers Teicon, Durakinase, and Lorelin Depot injections; produces various natural product materials, such as black cohosh extract and magnolia extract comprises ETIZM and TECA; and natural herb medicines.
In addition, it provides general and prescription-based drugs; medical devices; ETC and cosmetic products; and quasi drugs that include lipossol hydrocare bandage.
DongKook Pharmaceutical Co., Ltd. also exports its products to approximately 40 countries, including Japan, Europe, Central and South America, and India.
The company was formerly known as UEC & Co., Ltd. and changed its name to DongKook Pharmaceutical Co., Ltd. in March 1982.
DongKook Pharmaceutical Co., Ltd. was founded in 1968 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1968 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Joonho Song |
Contact Details
Address: 715 Yeongdong-daero Seoul South Korea | |
| Phone | 82 2 2191 9800 |
Stock Details
| Ticker Symbol | 086450 |
| Exchange | KOSDAQ |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7086450004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Joonho Song | Chief Executive Officer |
| Hong-Ki Kim | Chief Financial Officer |